S$0.83 0.0 0.0%
Last Trade - 04/04/16
| Market Cap | ÂŁn/a |
| Enterprise Value | ÂŁn/a |
| Revenue | ÂŁ188.6m |
| Position in Universe | th / 6135 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Mar | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016E | 2017E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 116.2 | 156.6 | 292.1 | 336.2 | 323.8 | 308.4 | +21.6% | ||||
| +379.1 | +41.2 | +466.1 | -72.1 | -64.0 | ||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Biosensors International Group, Ltd. develops, manufactures and markets medical devices for interventional cardiology and critical care procedures. The Company's segments include Critical care, Interventional cardiology, Cardiac diagnostic, and Licensing and royalties revenue. It offers devices and solutions in therapeutic area, including cardiovascular, endovascular, critical care and cardiac imaging. In the cardiovascular area, the Company focuses on drug-eluting stents, drug coated stents and bare metal stents, as well as angioplasty catheters for the treatment of coronary artery disease. Its endovascular product portfolio includes stenting and ballooning solutions for superficial femoral artery, and below the knee interventions. Its critical care products include vascular catheters, pressure monitoring kits and blood pressure transducers. It offers D-SPECT, a nuclear cardiac imaging system. Its products include BioFreedom, BioMatrix Flex, Axxess, Chroma, Gazelle and BioStream.
| Last Annual | March 31st, 2015 |
| Last Interim | December 31st, 2015 |
| Incorporated | May 28, 1998 |
| Public Since | May 20, 2005 |
| No. of Shareholders: | 6,906 |
| No. of Employees: | 254 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | Singapore Exchange Securities Trading Ltd |
| Shares in Issue | 1,700,487,443 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 36 Jalan Tukang, 619266, Singapore |
| Web | http://www.biosensors.com/ |
| Phone | +65 6 2135777 |
| Contact | () |
| Auditors | Ernst & Young LLP |
As of 04/04/16, shares in Biosensors International are trading at S$0.83, giving the company a market capitalisation of ÂŁn/a. This share price information is delayed by 15 minutes.
Shares in Biosensors International are currently trading at S$0.83 and the price has moved by 7.79% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biosensors International price has moved by -17.01% over the past year.
There are no analysts currently covering Biosensors International.
Biosensors International is scheduled to issue upcoming financial results on the following dates:
Biosensors International does not currently pay a dividend.
Biosensors International does not currently pay a dividend.
Biosensors International does not currently pay a dividend.
To buy shares in Biosensors International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Biosensors International are currently trading at S$0.83, giving the company a market capitalisation of ÂŁn/a.
Here are the trading details for Biosensors International:
We were not able to load our ranking data for Biosensors International
We were not able to load any forecast data for Biosensors International.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biosensors International. Over the past six months, the relative strength of its shares against the market has been -3.08%. At the current price of S$0.83, shares in Biosensors International are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Biosensors International.
We were unable to find the directors for Biosensors International.
Here are the top five shareholders of Biosensors International based on the size of their shareholding:
